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ABSTRACT
Clostridium difficile spore germination is essential for colonization and disease. The signals that initiate C. difficile spore germi-
nation are a combination of taurocholic acid (a bile acid) and glycine. Interestingly, the chenodeoxycholic acid class (CDCA) bile
acids competitively inhibit taurocholic acid-mediated germination, suggesting that compounds that inhibit spore germination
could be developed into drugs that prophylactically prevent C. difficile infection or reduce recurring disease. However, a recent
report called into question the utility of such a strategy to prevent infection by describing C. difficile strains that germinated in
the apparent absence of bile acids or germinated in the presence of the CDCA inhibitor. Because the mechanisms of C. difficile
spore germination are beginning to be elucidated, the mechanism of germination in these particular strains could yield impor-
tant information on how C. difficile spores initiate germination. Therefore, we quantified the interaction of these strains with
taurocholic acid and CDCA, the rates of spore germination, the release of DPA from the spore core, and the abundance of the
germinant receptor complex (CspC, CspB, and SleC). We found that strains previously observed to germinate in the absence of
taurocholic acid correspond to more potent 50% effective concentrations (EC50 values; the concentrations that achieve a half-
maximum germination rate) of the germinant and are still inhibited by CDCA, possibly explaining the previous observations. By
comparing the germination kinetics and the abundance of proteins in the germinant receptor complex, we revised our original
model for CspC-mediated activation of spore germination and propose that CspCmay activate spore germination and then in-
hibit downstream processes.
IMPORTANCE
Clostridium difficile formsmetabolically dormant spores that persist in the health care environment. In susceptible hosts,C. difficile
spores germinate in response to certain bile acids and glycine. Blocking germination by C. difficile spores is an attractive strategy
to prevent the initiation of disease or to block recurring infection. However, certain C. difficile strains have been identified
whose spores germinate in the absence of bile acids or are not blocked by known inhibitors of C. difficile spore germination
(calling into question the utility of such strategies). Here, we further investigate these strains and reestablish that bile acid activa-
tors and inhibitors of germination affect these strains and use these data to suggest another role for the C. difficile bile acid ger-
minant receptor.
Spore formation and germination by Peptoclostridium difficilespores (1) (referred to here as Clostridium difficile for simplic-
ity) are significant hurdles for overcoming the transmission of this
pathogen within the hospital environment. Due to the strict an-
aerobic nature of C. difficile vegetative cells, spores are thought to
be the main reservoir for transmission within the health care set-
ting (2, 3). Prior antibiotic treatment is the greatest risk factor for
C. difficile infection (4). Broad-spectrum antibiotics alter the bal-
ance of the colonic microbiota allowingC. difficile an opportunity
to colonize the newly generated niche (5–7). Once in a host, C.
difficile spores germinate to form the toxin-producing vegetative
cells that colonize a host’s colonic environment. In susceptible
hosts,C. difficile vegetative cells secrete two toxins that damage the
colonic epithelium and lead to the primary symptoms of disease
(8, 9). C. difficile infections are commonly treated with more an-
tibiotics (e.g., metronidazole, vancomycin, or fidaxomicin) (10).
After disease symptoms are alleviated and the antibiotics are dis-
continued, patients frequently relapse with recurring disease due
to germination by spores that remain in the colon or that reinfect
the host from the surrounding environment (10). Because germi-
nation by the spore form is required for pathogenesis, compounds
that prevent spore germination could be an attractive way to pre-
vent the primary or recurring infections (11–13).
Endospores are dormant forms of bacteria and are formed by
vegetative cells in response to environmental stress (14, 15). In
Bacillus subtilis, sporulation is a tightly regulated process and in-
volves the formation of a forespore within a mother cell (16). The
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forespore and mother cell communicate through a cascade of
sigma factor activation and waves of transcription/translation
(16). The result of this developmental program is a dormant spore
consisting of a DNA-containing core wheremuch of the water has
been replaced by dipicolinic acid as a calcium chelate (CaDPA)
(17). Surrounding the spore core is an inner spore membrane, a
thin germ cell peptidoglycan layer, a thick cortex peptidoglycan
layer, an outer spore membrane, and layers of coat protein (15).
The coat proteins, cortex, and the contents of the desiccated core
help protect the spore from environmental stressors (e.g., heat,
radiation, chemicals, and antibiotics) and keep the spore in amet-
abolically dormant state (15, 17).
Endospore germination has been extensively studied in B. sub-
tilis (15). In B. subtilis, spore germination can be initiated when
L-alanine (a germinant) interacts with the GerAA-AB-AC germi-
nant receptor which is embedded within the inner spore mem-
brane (15). This interaction triggers the release of the large depot
of CaDPA, presumably through the SpoVA membrane channel
(15). This results in the partial hydration of the spore’s core. As
CaDPA passes through the cortex layer, CaDPA activates the CwlJ
cortex hydrolase and the actions of the CwlJ and SleB hydrolases
degrade the spore cortex, resulting in core expansion and full re-
hydration of the spore core (15).
The receptors with which spore germinants interact are con-
served between most of the studied spore-forming bacteria (e.g.,
B. subtilis, B. anthracis, and C. perfringens), while the germinants
which activate spore germination vary between organisms (but
germinants are generally amino acids, nucleotides, ions, or sugars)
(18). C. difficile spore germination is initiated by certain bile acids
(presumably a host signal) and glycine (presumably a nutrient
signal) (14, 19–21). Bile acids are small, steroid acids that are re-
leased by the gallbladder into the digestive tract to aid in the ab-
sorption of fats and cholesterol (22). Two families of bile acids
are synthesized by the liver: cholic acid derivatives and chenode-
oxycholic acid derivatives (CDCA). Each of these families is
conjugated with either a taurine (taurocholic acid [TA] or tauro-
chenodeoxycholic acid) or a glycine (glycocholic acid or glycoche-
nodeoxycholic acid) (22). C. difficile spore germination is stimu-
lated by cholic acid, while CDCA derivatives inhibit cholic
acid-mediated germination (11, 19, 23, 24). Based on previous
studies, C. difficile spores correspond to 50% effective concentra-
tions (EC50 values; the concentrations that achieve a half-maxi-
mum germination rate) in the low-millimolar range for TA and
the high-micromolar range for CDCA, suggesting that C. difficile
spores may have a tighter interaction with inhibitors of germina-
tion than with the activators of germination (11, 23–25).
Although the signals that stimulate spore germination have
been studied for some time, only recently was the receptor with
which the bile acids interact identified (13). C. difficile does not
encode the classical, membrane-embedded, ger-type, germinant
receptor (26). Instead, C. difficile spore germination proceeds
through a novel germination pathway involving direct stimula-
tion of cortex hydrolysis and subsequent release of CaDPA from
the spore core (opposite to what is observed for germinant recep-
tor-mediated germination inB. subtilis orClostridiumperfringens)
(13–15, 27, 28). In our working model, C. difficile spore germina-
tion is initiated when the germination-specific, pseudoprotease,
CspC, interacts with the cholic acid class of bile acids (13). Acti-
vated CspC transmits the bile acid activating signal to the CspB
protease, which then activates the spore cortex lytic enzyme SleC
(deposited in the spore as a zymogen) (13, 29). Activated SleC
then begins to degrade the spore cortex, and CaDPA is subse-
quently released from the spore core (27, 28).
Based on the model described above, all C. difficile isolates
should have the requirement for bile acids to stimulate germina-
tion. Indeed, spores derived from most clinical isolates require
taurocholic acid (TA) to initiate spore germination in rich me-
dium (30, 31). However, a few isolates have been reported not to
require TA as a spore germinant or not to be inhibited the CDCA
antigerminant (31). If these strains have no requirement for TA or
are not inhibited by CDCA, by what mechanism would they be
activated for germination (i.e., would the mechanisms for germi-
nation in these strains be different from what has been described
previously)?
We sought here to reexamine the germination of spores de-
rived from C. difficile strains that were reported previously to ger-
minate in rich medium alone or germinate in the presence of a
known inhibitor of C. difficile spore germination, CDCA (31) and
compare this germination to that of spores that clearly require TA
for germination (11, 25, 27, 32). Upon reinvestigation of these
strains, we found that strains previously thought not to be inhib-
ited by CDCA are actually inhibited by CDCA and interact with
CDCA with inhibitor constant values similar to those for other
strains. However, these strains do exhibit greater EC50 values for
TA (EC50,TA values), possibly explaining previous observations
(31). We further characterize these strains by determining the
abundance of the germinant receptor complex and show that the
levels of CspC, CspB, and SleC differ between strains. By compar-
ing the generated kinetic data with the abundance of spore pro-
teins, we revise our model for the mechanism of initiating C. dif-
ficile spore germination. Based on our prior genetic data and the
data herein, we propose that CspC acts to initiate spore germina-
tion in the presence of TA but then to inhibit downstream pro-
cesses until another signal is received.
MATERIALS AND METHODS
Strains and growth conditions. C. difficile strains (see Table S1 in the
supplemental material) were grown in a Coy Laboratories model B anaer-
obic chamber (10%H2, 5%CO2, 85%N2) at 37°C in brain heart infusion
supplemented with 5 g/liter yeast extract and 0.1% L-cysteine (BHIS), as
described previously (13, 27, 32, 33). Escherichia coli routinely was grown
at 37°C in Luria-Bertani (LB) medium or in 2TYmedium (5 g of NaCl,
10 g of yeast extract, and 16 g of tryptone/liter) for protein expression (see
below). Antibiotics were supplemented as needed (100g/ml ampicillin).
Molecular biology. The C. difficile UK1 sleC gene was amplified with
PhusionDNApolymerase (NewEnglandBioLabs, Beverly,MA) using the
primers 5=pET_SleC (TTTTGTTTAACTTTAAGAAGGAGATATACAT
ATGCAAGATGGTTTCTTAACAGTAAGC) and 3=pET_SleC (ATCTCA
GTGGTGGTGGTGGTGGTGCTCGAGAATTAAAGGATTTAAAGAA
GCTATT). The resulting PCR product was inserted into pET22b between
the XhoI andNdeI restriction sites usingGibsonAssembly (34) and trans-
formed into E. coli DH5 to generate pKS08. To construct a strain pro-
ducing CspB for recombinant protein expression, the cspB gene was am-
plified with Phusion DNA polymerase from C. difficile UK1 genomic
DNAwith the primers 5=CO_cspB (GTTTAACTTTAAGAAGGAGATAT
ACATATGATTATCATTAATTACGAACTGATTGTGAAG) and 3=CO_
cspB_CPD (TTCCATCCGCGAGCTCGCTTTTATTAATGCTGCG). To
aid in solubility and allow for the generation of an untaggedCspB protein,
the cysteine protease domain from the Vibrio cholerae MARTX protease
(CPD) was fused to the 3= end of cspB (35). cpd was amplified from the
pcspC-CO-50CPD plasmid using the primers 5=CPD_cspB (CGCAGCA
TTAATAAAAGCGAGCTCGCGGATGGAA) and 3=CPD_pET (ATCTC
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AGTGGTGGTGGTGGTGGTGCTCGAGACCTTGCGCGTCCCA). The
resulting cspB and cpd PCR products were inserted into pET22b between
restriction sites XhoI and NdeI using Gibson Assembly (34), and the re-
sulting plasmid was named pKS02. The C. difficile cspC gene was codon
optimized for expression in E. coli (Eurofins Genomics, Ebersberg, Ger-
many). The resulting gene was subcloned into pET22b-CPD (35). The
sequences of all inserts were verified.
Spore preparation. Spores were generated and purified as described
previously (13, 25, 27, 32). Briefly,C. difficile strains were streaked onto 10
to 15 plates of BHIS agarmedium.After 4 days, the growth fromeach plate
was scraped into 1ml of sterile water and incubated overnight at 4°C. The
following day, the growth suspension was washed five times in sterile
water. During each wash step, the layer of white cell debris was removed.
After washing, the spores/cell debris were suspended in 25% (wt/vol)
HistoDenz (Sigma-Aldrich, St. Louis, MO) and layered onto a 50% (wt/
vol) HistoDenz solution. The resulting gradient was centrifuged at
18,900 g for 30min. During centrifugation, spores migrate through the
50% HistoDenz, while the less-dense vegetative cells and cell debris re-
main at the interface. After centrifugation, the solution is removed, and
the pellet, containing the purified spores, was washed five times in sterile
water before being resuspended in a final volume of 1 ml. Purified spores
were examined microscopically and found to be99.9% pure and phase
bright (dormant).
Germination. To quantify the interaction between the bile acids and
C. difficile spores, purified spores were heat activated at 65°C for 30 min
and then placed on ice. Ten microliters of the heat-activated spores were
added to a final optical density at 600 nm (OD600) of 0.5 in 990l of BHIS
medium alone or medium supplemented with the indicated concentra-
tions of bile acids and germinationwasmonitored at 600 nm for 15min in
a Perkin-Elmer (Waltham, MA) Lambda25 UV/Vis spectrophotometer.
The data points atOD600 (Tx)were normalized to the startingOD600 value
(T0). Germination rates and EC50 values were calculated using the slopes
of the linear portions of the germination plots, as described previously
(11, 25). The data shown in Fig. 1 and 2 are representative of three inde-
pendent experiments (the data cannot be averaged between experiments
due to differences in time points generated by the Perkin-Elmer spectro-
photometer). (For transparency, all germination plots are included Fig. S1
FIG 1 Bile acid-mediated spore germination of several C. difficile strains.
Purified C. difficile spores were suspended in BHIS medium alone () or
medium supplemented with 2 mM (), 5 mM (Œ), 10 mM (), 20 mM (}),
or 50 mM (Œ) TA. Germination was monitored at OD600 as described previ-
ously. (A)C. difficileUK1; (B)C. difficile 5108111; (C)C. difficileCD2315; (D)
C. difficileDH1834; (E) C. difficileDH1858; (F) C. difficileM68; (G) C. difficile
M120. A representative sample from three independent experiments is shown.
For transparency, all plots are shown in Fig. S1 in the supplemental material.
FIG 2 Chenodeoxycholic acid inhibits C. difficile spore germination. Purified
C. difficile spores were suspended in BHIS medium supplemented with 1 mM
CDCA () ormedium supplementedwith 2mM (), 5mM (Œ), 10mM (),
20mM(}), or 50mM(Œ) TA and 1mMCDCA.Germinationwasmonitored
at OD600 as described previously. (A) C. difficile UK1; (B) C. difficile 5108111;
(C) C. difficileCD2315; (D) C. difficileDH1834; (E) C. difficileDH1858; (F) C.
difficile M68; (G) C. difficile M120. A representative sample from three inde-
pendent experiments is shown. For transparency, all plots are shown in Fig. S3
in the supplemental material.
Reexamining C. difficile Spore Germination
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to S3 in the supplemental material.) The rates and EC50 values were indi-
vidually calculated from each germination experiment and are reported as
averages with the standard error of the mean.
The release of CaDPA from germinating C. difficile spores was moni-
tored in real time using terbium fluorescence (36). An opaque, 96-well
platewas preparedwith 125l of 10mMTris (pH7.5), 150mMNaCl, 800
MTbCl3, and 100 mM glycine alone or supplemented with 10 mM TA,
as described previously (27). Heat-activated spores were then sedimented
for 1 min at 14,000 g and resuspended in an equal volume of water to
remove any CaDPA that may have been released due to autogerminating
spores. A 5-l sample of a spore suspension (OD600 60) was added to
each well, and the CaDPA release was monitored in a Molecular Devices
(Sunnydale, CA) Spectramax M3 fluorescence plate reader. CaDPA re-
lease wasmonitored with the following settings: excitation, 270 nm; emis-
sion, 545 nm; and cutoff, 420 nm. The CaDPA release data are reported as
the average of three independent experiments, and error bars represent
the standard errors of the mean.
The total DPA content of the spores was determined by suspending
105 spores in buffer, followed by incubation at 95°C for 30min. The spores
were cooled and sedimented for 2 min at 14,000  g. The amount of
released DPA was determined as described above using terbium fluores-
cence.
Protein purification. Overnight cultures of the appropriate
BL21(DE3) strains were diluted 1:200 in 2TYmedium and incubated at
200 rpm and 37°C. When an OD600 of 0.6 to 0.8 was reached, IPTG
(isopropyl--D-thiogalactopyranoside) was added to a 250Mfinal con-
centration, and cultures were grown at 16°C for 12 to 14 h. Subsequently,
the cultureswere pelleted at 6,000 rpmand 4°C for 30min and then frozen
at 	80°C. Cell pellets were resuspended in LIB1 (50 mM Tris [pH 7.5],
500 mMNaCl, 15 mM imidazole, and 10% glycerol) and lysed by sonica-
tion. HisPur Ni-NTA resin (Thermo Scientific) was added to the clarified
supernatants and washed with LIB2 (50 mM Tris [pH 7.5], 300 mM so-
dium chloride, 30 mM imidazole, and 10% glycerol). For SleC6His, the
resulting protein was eluted from theNi-resin in LIB1 supplemented with
500 mM imidazole. For CspB-CPD6His and CspC-CPD6His, all proteins
were cleaved from the CPD tag in LIB1 supplemented with 75 M (final
concentration) phytic acid at room temperature for 20 min with shaking
(four cleavage reactions were sufficient to cleave the respective proteins
from the CPD tag). The volume of the phytic acid cleavings was equal to
the Ni-bead bed volume. The resulting proteins were analyzed for their
purity by SDS-PAGEandCoomassie blue staining andquantified byusing
a NanoDrop apparatus.
Protein extraction and Western blotting. NuPAGE soluble proteins
(which include CspB, CspC, and SleC) were extracted from 2  109/ml
purified spores as described previously (37). A separate spore extract from
2 109 C. difficile JSC11 (cspBA::ermB) spores or C. difficile CAA5 (sleC::
ermB) spores was also generated. Standard amounts of NuPAGE-solubi-
lized recombinant proteins (generated above) were added to a 10% so-
dium dodecyl sulfate (SDS)–polyacrylamide gel (a standard curve was
generated on every gel run). An equal volume of extract from mutant
spores was added to the wells containing the recombinant protein stan-
dard to allow for equal transfer efficiencies between recombinant protein-
containingwells and extract wells. Proteins were separated by SDS-PAGE.
After separation, the gels were transferred overnight at 30 V to a low-
fluorescence polyvinylidene difluoride membrane (Bio-Rad). Subse-
quently, the membrane was blocked for 1 h at room temperature with
10% dried, skimmed milk in Tris-buffered saline (TBS). Each membrane
was washed thrice for 15 min each with TBS containing 0.1% (vol/vol)
Tween 20 (TBST). The membrane was then incubated at room tempera-
ture with either rabbit anti-CspC, anti-CspB, or anti-SleC antibodies. Af-
ter incubation with the primary antibody, membranes were washed as
described above in TBST. The membranes were then labeled with Alexa
Fluor 555-labeled donkey anti-rabbit IgG (Life Technologies) in the dark
for 2 h at room temperature. The membranes were again washed as de-
scribed above but in the dark. Finally, the fluorescent signal on the mem-
braneswere detected by scanning on aGETyphoon Scanner using theCy3
setting (appropriate wavelength for Alexa Fluor 555). The resulting scans
were quantified using ImageQuant TL 7.0 image analysis software pro-
vided by GE.
Statistical analyses. Statistical analysis between the calculated EC50,TA
or inhibitor constant (CDCA) values was accomplished with a one-way
analysis of variance with Tukey’s test for multiple comparisons. A 99%
confidence interval was set for significance (P
 0.01).
RESULTS
Taurocholic acid-induced germination by several C. difficile
isolates. There have been recent reports describing heterogeneity
of spore germination between C. difficile strains (30, 31). Some of
these strains appeared to germinate in richmedium in the absence
of the TA germinant. Other strains were not inhibited by CDCA
(31). This calls into question the impact bile acids may have on C.
difficile infection and the utility of germination/antigermination-
based therapies. Although there are undoubtedly differences in
germination responses between C. difficile strains, the lack of in-
hibition by CDCA and germination in the absence of TA war-
ranted further investigation.
Germination by C. difficile strains UK1 and M68 have been
described previously by our lab and spore germination by these
strains is activated by TA and inhibited by CDCA (25). We also
analyzed germination by C. difficile strains 5108111, DH1834,
DH1858, CD2315 (generously provided by Nigel Minton), and
M120. Of these, spores derived from C. difficile strains 5108111,
DH1834, andCD2315were reported not to be inhibited byCDCA
(spore germination by DH1858 was inhibited by CDCA) (31). To
quantitate the differences in germination responses between iso-
lates, we determined the EC50 values for taurocholic acid and
spores from differentC. difficile strains. These types of assays have
been useful to determine the potency of activators and inhibitors
of germination (11, 24, 25, 38–40). Although not traditional en-
zyme kinetics (spore germination is amultienzyme process), these
studies can provide a quantitative measure for the interaction of
the bile acids and C. difficile spores. C. difficile spores were sus-
pended in BHIS medium alone or in medium supplemented with
increasing TA concentrations (2, 5, 10, 20, or 50 mM) and germi-
nationwasmonitored atOD600. These TA concentrations are rou-
tinely used by our laboratory to assign EC50 values for bile acids.
As shown in Fig. 1 and in Fig. S1 in the supplemental material,
BHIS medium alone did not stimulate germination of the seven
strains tested, suggesting a requirement for TA to initiate spore
germination in rich medium. However, when supplemented with
increasing concentrations of TA, C. difficileUK1, M68, andM120
(Fig. 1A, F, and G, respectively) exhibited a concentration-depen-
dent increase in the rate of germination. Interestingly, C. difficile
strains 5108111, CD2315, DH1834, and DH1858 achieved near-
maximum germination rates at the lowest tested TA concentra-
tion (BHIS 2mMTA) (Fig. 1B to E; see also Fig. S1B to E in the
supplemental material).
Because these strains germinated at near-maximum rates in
the lowest tested TA concentration, we modified our germination
conditions to determine whether these strains are capable of ger-
minating at even lower TA concentrations (see Fig. S2 in the sup-
plemental material). When germination by C. difficile strains
5108111, CD2315, DH1834, and DH1858 were tested at lower TA
concentrations, we observed dose-dependent increases in germi-
nation rates. From the newly generated germination plots, we gen-
erated rate curves and EC50,TA values (Table 1). Spores from C.
Bhattacharjee et al.
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difficile UK1 and C. difficile M68 generated EC50,TA values similar
to those described previously (25). C. difficile DH1834, DH1858,
and M120 had similar EC50,TA values (3.0, 3.03, and 2.37, respec-
tively), and these values are similar to those for UK1 and M68.
Interestingly, compared to the other tested strains, C. difficile
5108111 and CD2315 had statistically significant increased EC50
values for TA (Table 1), suggesting that spores derived from these
strains require less TA to activate spore germination.
CDCA-dependent inhibition of C. difficile spore germina-
tion. Because we observed that some C. difficile strains (5108111
and CD2315) exhibited a more potent interaction with TA, we
tested whether there were differences in the interaction with
CDCA. C. difficile spores were suspended in BHIS medium or
BHIS medium supplemented with 1 mM CDCA and increasing
concentrations of TA (2, 5, 10, 20, or 50 mM), and germination
was monitored at OD600. CDCA completely inhibited germina-
tion of the 2 mMTA sample for spores derived from all C. difficile
strains except C. difficile strain CD2315. Interestingly, CDCA had
less of an effect on germination by C. difficile CD2315 spores (Fig.
2C). However, CDCA still affected its ability to respond to TA as a
germinant. Upon comparing Fig. 1C to Fig. 2C, it is evident that
germination by C. difficile CD2315 spores clearly is affected by
CDCA.
Inhibition constants were generated from the curves in Fig. 2
and Fig. S3 in the supplemental material and the calculated
EC50,TA (Table 1). C. difficile UK1 spores and C. difficile M68
spores generated inhibitor constant values similar to those re-
ported previously (Table 1) (25), and all strains generated values
near or below 0.5 mM. Spores derived from C. difficile 5108111
had the weakest interaction with CDCA (0.52 mM; P 
 0.01)
compared to the other strains. These results suggest that CDCA
inhibits germination by spores of C. difficile strains previously
thought not to be affected by the inhibitor.
Although the germination of all strains was inhibited by
CDCA, the effectiveness of the inhibitor varied. When the inhibi-
tion ratio (the ratio of the EC50,TA and the inhibitor constant) was
calculated, the ratio for most strains was greater than 10, suggest-
ing that germination is strongly inhibited by CDCA in these
strains (Table 1). Germination byC. difficile 5108111 andCD2315
spores was not strongly inhibited by CDCA (the same strains with
an increased EC50,TA) (Table 1). Taken together, the results sug-
gest that, although there are differences in the interactions of the
spores with the bile acids, all tested strains are inhibited by CDCA
and are activated by TA.
To determine whether the observed differences in the interac-
tion of the bile acids with the C. difficile spores correlated with
specific alterations in the CspB, CspA, or CspC protein sequences,
we sequenced the cspBAC locus from each strain (see Fig. S4 to S6
in the supplemental material). All ribotype 027 isolates (UK1,
5108111, DH1834, and DH1858) had identical CspC sequences,
whereas ribotypes 078 (CD2315 andM120) and 017 (M68) had 26
substitutions between them (see Fig. S4 in the supplemental ma-
terial). C. difficile CD2315 had a P317L substitution that was not
present in any of the other tested strains (see Fig. S4 in the supple-
mental material). The CspB sequence only varied in ribotype 078
strains (see Fig. S5 in the supplemental material) with 13 substi-
tutions. The CspA proteins varied most between the three Csp
proteins, with a total of 42 substitutions (see Fig. S6 in the supple-
mental material). With the exception of the CD2315 CspCP317L
substitution, all substitutions were consistent between ribotypes.
Because substitutions were ribotype specific but the EC50,TA and
inhibitor constants were not, these results suggest that the ob-
served differences are not due to specific changes in the CspB,
CspA, or CspC sequences.
Taurocholic acid is required for C. difficile spore germina-
tion. Previously, germination by C. difficile strains 5108111,
DH1834, DH1858, and CD2315 occurred slowly but in the ab-
sence of the TA germinant (31). To further investigate the phe-
nomenon, we utilized an assay which measures the release of
CaDPA from the spore core during germination (CaDPA release
is a requirement for spore germination). Because this assay is (i)
based on the detection of fluorescent CaDPA-Tb3 complexes
and not OD and (ii) each well is mixed prior to analysis, this assay
eliminates any chance of spores settling, clumping, and/or local-
izing to the center of a well during the 4-h incubation. C. difficile
spores were suspended in germination buffer supplemented with
glycine only (nongerminating conditions) or TA and glycine (ger-
mination-inducing conditions) and Tb3 fluorescence was mon-
itored for 4 h (see Fig. S7 in the supplemental material). Spores
from all C. difficile strains tested released CaDPA, which resulted
in Tb3 fluorescence when suspended in both TA and glycine.
Spores suspended in glycine alone did not release CaDPA during
the 4-h assay. These results suggest that these strains require TA to
induce germination in combination with glycine and have a low
frequency of autogermination.
The data presented in Fig. S7 in the supplemental material
suggest that all tested strains have a requirement for TA to stimu-
late germination in combination with the glycine cogerminant,
but not if these strains require glycine to germinate. Therefore, we
tested CaDPA release in the absence of glycine (Fig. 3). C. difficile
strains UK1 (Fig. 3A), 5108111 (Fig. 3B), DH1834 (Fig. 3D),
DH1858 (Fig. 3E), M68 (Fig. 3F), andM120 (Fig. 3G) all required
the presence of both TA and glycine to germinate. Interestingly,C.
difficile CD2315 (Fig. 3C) slowly, but significantly, germinated in
the presence of TA alone. However, germination by CD2315
spores was enhanced strongly by the presence of glycine (Fig. 3C).
These results suggest that glycine is a cogerminant for spores of the
tested strains but that C. difficile CD2315 spores can release
CaDPA slowly in the absence of glycine.
To further characterize the differences between these strains,
we analyzed the amount of CaDPA present within the core of each
TABLE 1 Quantifying the interaction of C. difficile spores with bile acids
Strain
Mean SDa
Inhibition
ratiob
Apparent EC50,TA
(mM)
Inhibitor constant
(mM)
UK1 2.95 0.23 0.21 0.07 14.0
5108111 0.76 0.14* 0.52 0.03* 1.5
CD2315 0.42 0.07* 0.18 0.03 2.3
DH1834 3.00 0.45 0.21 0.08 14.3
DH1858 3.03 0.36 0.29 0.07 10.4
M68 3.35 0.39 0.12 0.02 27.9
M120 2.37 0.14 0.17 0.02 13.9
a The apparent EC50,TA and inhibitor constant values were calculated from the
germination curves, as described previously (11, 25, 32). Inhibitor constant
[inhibitor]/{(EC50,TA with inhibitor)/[(EC50,TA without inhibitor)	 1]}. For statistical
comparisons, EC50,TA values were compared to each other, and inhibitor constant
values were compared to each other as described in Materials and Methods. *, P
 0.01.
b Inhibition ratio EC50,TA/inhibitor constant.
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strain and normalized this to the amount found inC. difficileUK1
(Fig. 3H). For all strains, 105 spores were boiled in buffer and
sedimented, and the amount of CaDPA was determined using
Tb3 fluorescence. As shown in Fig. 3H, the amount of CaDPA
present in C. difficile spores varied between strains (although only
by 2-fold in the lowest DPA-containing strain, C. difficile
DH1834).
Germinant receptor levels vary between C. difficile strains.
To begin to understand how different C. difficile isolates display
different EC50 or inhibitor constant values for bile acids, we ana-
lyzed the abundance of CspB, CspC, and SleC in purified C. diffi-
cile spores. Purified C. difficile spores were extracted with Nu-
PAGE buffer, as described previously (37). We found that by
boiling spores inNuPAGE buffer, the amount of remaining CspB,
CspC, or SleC in the NuPAGE insoluble fraction (containing un-
broken spores) was below the limit of detection. Known amounts
of the recombinant CspC, CspB, or SleC protein and spore ex-
tracts were separated by SDS-PAGE and detected using rabbit
polyclonal antisera, followed by Alexa Fluor 555-conjugated don-
key anti-rabbit IgG. The standard curves generated from the sig-
nals on each SDS-PAGE were linear (Fig. 4). From the signal in-
FIG3 DPA release by severalC. difficile strains. PurifiedC. difficile spores were
suspended in HEPES buffer () or buffer supplemented with 10mMTA (),
100 mM glycine (Œ), or 10 mM TA and 100 mM glycine (). DPA release
during spore germination was monitored using Tb3 fluorescence, as de-
scribed previously. (A) C. difficile UK1; (B) C. difficile 5108111; (C) C. difficile
CD2315; (D) C. difficile DH1834; (E) C. difficile DH1858; (F) C. difficile M68;
(G) C. difficile M120. (H) Purified C. difficile spores were suspended in buffer
and incubated at 100°C for 30 min. Total DPA content was normalized to the
amount of DPA found in C. difficile UK1. All data represent the average from
three independent experiments, and error bars represent the standard devia-
tions from the mean.
FIG 4 Quantifying the abundance of CspB, CspC, and SleC in C. difficile
spores. A total of 109 C. difficile UK1 spores were extracted with NuPAGE
buffer, as described previously. NuPAGE-soluble protein from three indepen-
dent extracts was loaded onto a 10% SDS-polyacrylamide gel, along with re-
combinantly expressed and purified protein, as a protein standard. Samples
were separated and detected as described in Materials and Methods. Signal
intensities were quantified and used to generate a standard curve for CspB (A),
CspC (B), and SleC (C). Signal intensities in the spore extract samples were
quantified, and the generated standard curve was used to quantify the abun-
dance of the specified proteins in the spore extracts. Independent standard
curves were generated for each strain, and the results of the quantification can
be found in Table 2. **, Full-length pre-pro-SleC; *, pro-SleC.
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tensities of the extracted CspB (Fig. 4A), CspC (Fig. 4B), and SleC
(Fig. 4C), the volume loaded onto the SDS-PAGE, the molecular
weights of each protein, and the amount of spores extracted, we
were able to determine the average abundance of each protein in a
C. difficile spore (Table 2).
The abundance of these proteins varied between C. difficile
isolates. For example, C. difficile UK1 had 2,000 CspC molecules
per spore, while C. difficile M68 had more than 3,800. Interest-
ingly, C. difficile CD2315 and C. difficile M120 had a very low
abundance of CspB (435 and 633 molecules per spore, respec-
tively). As described previously for C. perfringens, the average
amount of SleC per spore was greater than that of both CspC and
CspB but also varied between strains (Table 2) (41).
Prior work has suggested that much of the OD change ob-
served during spore germination is due to the release of CaDPA
from the spore core (42). During C. difficile spore germination,
this event is dependent on the hydrolysis of the spore cortex by
SleC (27). Because SleC is deposited into the spore as a zymogen,
SleCmust be activated by CspB in order to stimulate germination.
In our original model for bile acid mediated spore germination,
CspB is activated by the CspC germinant receptor. Because the
abundance of CspC varied between isolates, we determined
whether the maximum rate of spore germination correlated with
the abundance of CspC. Thus, for each strain we calculated the
maximum rate of germination from the germination curves used
to calculate the EC50,TA (Table 3). Surprisingly, there was a slight
trend for an inverse correlation of the abundance of CspC and rate
(R2  0.32) (Fig. 5A), suggesting that CspC may have an inhibi-
tory effect on spore germination.
Because SleC-mediated cortex hydrolysis is required for
CaDPA release during C. difficile spore germination, if the above
trend is true we should observe a positive correlation between the
ratio of SleC to CspC and germination rate (more SleC molecules
to CspC molecules should result in an increased rate of germina-
tion). As shown in Fig. 5B, we observed a strong correlation (R2
0.81) between SleC/CspC and germination rate, again suggesting
that CspC has an inhibitory effect on spore germination.
DISCUSSION
Spore germination is an important step in the life cycle of any
spore-forming organism. Themetabolically dormant sporesmust
sense when conditions again become favorable for growth and
quickly respond to the germinants used by that bacterium. Ger-
mination in an environment unfavorable for growth could pre-
vent the outgrowth of a vegetative cell from the germinated spore
or prevent the vegetative growth of that bacterium. Thus, the sig-
nals that stimulate germination (germinants) can vary between
organisms depending on their growth niche. For example, C. dif-
ficile vegetative cells are not normally found growing outside a
host; thus, it would be logical for C. difficile spores to respond to a
molecule that is host specific. In fact,C. difficile spore germination
is activated by cholic acid-class bile acids (e.g., TA) and is inhibited
by chenodeoxycholic acid-class bile acids (e.g., CDCA) (11, 14, 19,
23). Although essential, TA is not sufficient to stimulateC. difficile
spore germination. Glycine is also required, presumably as a mea-
sure of the nutrient status of the surrounding environment (19,
43, 44).
Until recently, most of the studies on C. difficile spore germi-
nation have relied on identifying germinants and their interac-
tions with bile acids, bile acid analogs, amino acids, and amino
acid analogs (11, 19, 23–25, 39, 45, 46). Only recently have the
mechanisms of C. difficile spore germination been studied, largely
due to breakthroughs in genetics (47–51). These breakthroughs
allowed us to determine that the germination-specific, pseudo-
protease, CspC, is the bile acid germinant receptor.
The germination-specific proteases have largely been studied
TABLE 2 Number of Csp molecules per C. difficile spore
Strain
Avg SDa
SleC/CspC
ratioCspB CspC SleC
UK1 1,394 426 2,141 164 46,090 5,089 21.5
5108111 3081 154 2,304 209 31,614 3,497 13.7
CD2315 435 86 1,689 137 41,239 1,832 24.4
DH1834 1,178 120 3,155 139 37,876 2,027 12.0
DH1858 1,572 60 1,435 154 37,557 827 26.2
M68 1,284 160 3,836 541 46,685 3,507 12.2
M120 633 36 2,423 203 29,473 1,724 12.2
a The average numbers of molecules of CspB, CspC, and SleC were calculated as
described in the legend to Fig. 4. The numbers represent three independent extractions.
TABLE 3 Rates of C. difficile spore germination
Strain
Germination rate (mean
OD 10	3/s SD)a
UK1 1.47 0.092
5108111 1.30 0.082
CD2315 1.67 0.047
DH1834 1.23 0.047
DH1858 1.62 0.11
M68 1.35 0.054
M120 1.04 0.043
a The rates of spore germination were calculated by using the linear portion of the
germination curves, as described previously (11, 25, 32). Values represent three
independent experiments.
FIG 5 Correlating the abundance of C. difficile proteins with the kinetics of
spore germination. (A) The calculated average per spore abundance of CspC
was plotted versus the calculated rates of spore germination. (B) The ratio of
SleC to CspC was plotted versus the calculated rates of spore germination. For
all plots, GraphPad Prism was used to generate the linear fit to the curves, and
the listed R2 values represent the fit of the curve to the data.
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inC. perfringens (41, 52–54). InC. perfringens theCspA,CspB, and
CspC proteins are all catalytically active proteases that can cleave
the cortex hydrolase, SleC, to an active form. InC. difficile, the cspB
and cspA genes have been translationally fused and yield CspBA
upon translation (26, 29). The CspBA protein undergoes interdo-
main processing by the YabG protease to generate CspB andCspA
(55).We proposed amodel whereby activated CspC transmits the
signal to the CspB protease, which then activates SleC. In support
of this model, we found that CaDPA release from the core is de-
pendent on hydrolysis of the spore cortex (27).
If SleC activation occurs prior toCaDPA release from the spore
core and if SleC-mediated cortex hydrolysis is essential for germi-
nation to begin, allC. difficile strains should have the requirement
for bile acids to initiate germination (unless some C. difficile
strains germinate using yet another novel mechanism for spore
germination). However, some C. difficile strains were reported to
have no apparent requirement for TA-mediated germination or
whose germination was not inhibited by CDCA (31). If germina-
tion in these strains was not influenced by bile acids, by what
mechanism(s) were they germinating?
To characterize the germination phenotypes in these strains,
we determined the EC50,TA and inhibitor constant values for these
strains and strains previously shown to be activated by TA and
inhibited by CDCA. As suggested previously, the germination
characteristics of these strains varied and did not correlate with
ribotype (31). Importantly, though, we did observe that some
strains have increased EC50,TA values, while another had a reduced
inhibitor constant for CDCA (Table 1). These strains’ increased
potency toward TA could possibly explain previous observations
(31). Spores derived from strains 5108111,DH1834,DH1858, and
CD2315 were found previously to lose OD600 in rich medium in
the absence of apparent TA (bile acids can be found in blood and,
thus, animal products). Moreover, the authors found that germi-
nation of spores derived from strains 5108111, DH1834, and
CD2315 was not inhibited by the CDCA antigerminant. Impor-
tantly, strains whose germination was not inhibited by CDCA had
increased EC50,TA values. Because the prior work used only one
concentration of TA and CDCA (0.1% [1.8 mM] and 2 mM, re-
spectively), to test the effects of CDCA as an inhibitor, it is likely
that these strains’ increased EC50,TA overcame the inhibitory effect
of CDCA (31). By quantifying the interactions between spores
derived from these strains and TA/CDCA, we reestablish the im-
portance of bile acids in promoting and inhibiting germination in
these strains.
The differences in EC50,TA and inhibitor constants were not
consistent between ribotypes. A growing body of evidence sug-
gests that toxin production, sporulation and germination are not
correlated with ribotype (30, 31, 56). In support of this observa-
tion, the calculated EC50,TA and inhibitor constant values were not
attributed to specific substitutions within the CspB, CspA, or
CspC protein sequences, and the substitutions were ribotype spe-
cific. Of the three proteins, CspB had the fewest substitutions.
Because CspB is required to cleave pro-SleC, CspB is likely under
evolutionary pressure to perform this function. Interestingly,
CspC and CspA had 26 and 42 substitutions, respectively. The
many substitutions inCspA could suggest that of theCsp proteins,
it is under the least amount of selective pressure. Although the role
of CspA is unknown, the presence of CspA is important for con-
trolling the levels of the germinant receptor, CspC (55). Only one
strain, C. difficile CD2315, encoded an extra substitution in the
CspC protein sequence that was not present in the other 078 ri-
botype, P317L. Curiously, C. difficile CD2315 is the only strain
that germinated in buffered TA without the need for the glycine
cogerminant (although glycine still enhanced germination in this
strain, suggesting the spore still responds to glycine). Clearly,
more studies are needed to characterize the effects of these substi-
tutions on C. difficile spore germination.
We further characterized these strains by determining the av-
erage per spore abundance of CspB, CspC, and SleC (we could not
generate a standard curve for CspA—it is insoluble when recom-
binantly expressed). As expected, the number of molecules per
spore varied between isolates and did not correlate with ribotype
(Table 2). The abundance of each of these proteins is greater than
the amount of germinant receptors found in B. subtilis (57). How-
ever, the increased abundance of CspB and SleC found in the C.
difficile spore, compared to the B. subtilis germinant receptors, is
consistent with a recent publication describing the amount of
these proteins in C. perfringens (41). Moreover, as seen in C. per-
fringens, the amount of SleCwas greater than the amount of CspB.
The amount of CspC in the C. difficile spore was similar to CspB
but varied (Table 2).
By determining the kinetics of spore germination for severalC.
difficile strains, we were positioned to determine whether the ki-
netic properties of germination could be attributed to differences
in the abundance of germination-specific proteins (CspB, CspC,
and SleC). In B. subtilis, overexpression of the GerAA germinant
receptor results in an increase in the germination rate (as mea-
sured by the decrease in OD600 and by the release of CaDPA) (58).
Prior work has shown that much of the OD600 change that occurs
during germination is due to the release of CaDPA from the spore
core (42). In C. difficile, CaDPA release is dependent on SleC-
mediated cortex hydrolysis (27, 28). Thus, we hypothesized that
an increased abundance of SleC would correlate with an increased
rate of germination. Also, because SleC activity is dependent on
activation by CspB, an increased abundance of CspB could result
in more active SleC during germination and, thus, an increased
rate of germination. However, we did not observe any correlation
between the rate of spore germination and the abundance of the
SleC hydrolase or CspB protease. One possible explanation for
this could be that the abundance of both SleC and CspB in the C.
difficile spores are far past saturating levels, and any alteration in
the observed levels would have minimal effects on the rate of ger-
mination. Surprisingly, we observed a trend for an inversed cor-
relation between the rate of germination and CspC abundance
(the more CspC molecules/spore, the slower the rate of germina-
tion [Fig. 5A]).
If this correlation is true, we predicted that more SleC mole-
cules would be needed to overcome the potential inhibitory effect
CspC would have on C. difficile spore germination. Indeed, we
observed a strong correlation between SleC/CspC and the rate of
germination (Fig. 5B) (R2 0.81). These results suggest that, in-
stead of the activator function we originally hypothesized, CspC
may be acting to inhibit C. difficile spore germination.
If true, how would CspC function during germination? Our
prior genetic data suggest that CspC transmits the bile acid signal
to begin the germination process, though the mechanism is un-
clear (13). Recently, GerS was identified and recognized to play a
role during germination (59). GerS is a protein that is anchored to
the inner leaflet of the outer spore membrane (though the lipida-
tion ofGerS is not required for it to function during germination).
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Interestingly,C. difficilegerS strains have a defect in germination
but still cleave SleC to the active hydrolase form. This suggested
that SleC activity, somehow, is inhibited in this strain (59). Based
on the correlation between CspC and SleC abundance and our
kinetic data, we hypothesize that CspC activates CspB but inhibits
SleC activity in the absence of GerS. Investigating the biochemis-
try of this germinant receptor complex could lead to a greater
understanding of the mechanism of initiating C. difficile spore
germination.
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